Product logins

Find logins to all Clarivate products below.


René Böttcher

Associate Director for Discovery and Translational Science Consulting

René acts as Associate Director for Discovery and Translational Science Consulting at Clarivate. His team leverages network biology and machine learning to advance pharma and biotech customers’ research projects across a broad spectrum of areas, including target and biomarker identification, patient stratification and drug repositioning.

René has more than 10 years of experience as a computational biologist in both industry and academia. Through working in various fields including cancer biology, cellular signaling, molecular virology and network biology, René gathered a deep understanding of data processing (ETL), analyses, visualization and interpretation using a variety of molecular assay platforms.

René holds a PhD in Bioinformatics from Erasmus University Rotterdam (The Netherlands) and completed this Bachelors and Masters in Biosystems technology / Bioinformatics at the Technical University of Applied Sciences Wildau (Germany).

Latest news

News February 3, 2026
Clarivate Webinar “Intelligence Amplified in the Age of AI” Highlights How Trusted, Proprietary Data Powers Next Generation Innovation

London, UK – February 3, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age…

News February 2, 2026
Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities

London, UK – February 2, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100…

News January 28, 2026
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025